1. Occupational Exposure Risks & NIOSH Drug Classifications
Healthcare personnel who compound, transport, administer, or dispose of hazardous medications face significant occupational health risks, including mutagenicity, teratogenicity, secondary malignancies, and reproductive toxicity. The National Institute for Occupational Safety and Health (NIOSH) categorizes hazardous drugs into three distinct tables:
- Table 1: Antineoplastic Drugs: Cytotoxic chemotherapeutic agents including cyclophosphamide, fluorouracil, cisplatin, and doxorubicin.
- Table 2: Non-Antineoplastic Hazardous Drugs: Medications meeting hazardous criteria such as cyclosporine, tacrolimus, and spironolactone.
- Table 3: Reproductive Hazards: Medications presenting selective reproductive toxicity to pregnant or lactating healthcare personnel, such as ribavirin and ganciclovir.
Occupational exposure occurs primarily through dermal absorption, accidental ingestion, and inhalation of cytotoxic aerosols or chemical vapors generated during vial reconstitution, line priming, and disconnection.
2. USP <800> Containment Hierarchy & Engineering Controls
In accordance with USP <800> Standards, healthcare institutions must implement a tiered hierarchy of engineering controls to prevent vapor and aerosol leakage into patient care environments:
| Control Tier | Facility / Equipment Specification | Operational Requirement | Safety Target |
|---|---|---|---|
| Primary (C-PEC) | Class II Type B2 / Type A2 (externally vented) or Class III BSC | Externally vented, 100% exhausted HEPA-filtered air, continuous operation | Worker and aerosol containment |
| Secondary (C-SEC) | Dedicated negative-pressure compounding cleanroom (-0.01 to -0.03 in. w.c.) | >=30 Air Changes Per Hour (ACPH), ISO Class 7 buffer room | Containment of escaped volatiles |
| Supplemental (CSTD) | Closed System Drug-Transfer Devices (PhaSeal, Equashield, Tevadaptor, Cyto-Set) | Mandatory during nursing administration; recommended during compounding | 0% liquid leakage, zero aerosol escape |
| PPE Barrier | Chemotherapy gloves tested under ASTM D6978 | Double-gloving (changed q30m), low-permeability coated gown (changed q2-3h) | Dermal absorption prevention |
3. Closed System Drug-Transfer Device (CSTD) Mechanics
A Closed System Drug-Transfer Device (CSTD) mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system. CSTDs utilize two primary engineering principles:
- Physical Membrane Barrier CSTDs: Employ double elastomeric membranes with dry-connection technology that seal upon disconnection, preventing micro-droplet leakage and volatile aerosolization.
- Air-Cleaning / Filtration CSTDs: Utilize sealed expansion chambers with hydrophobic and toxic chemical-binding carbon filters to equalize vial pressure without venting cytotoxic fumes into room air.
Under USP <800>, the use of CSTDs is mandatory during antineoplastic administration by nurses at the bedside and strongly recommended during sterile compounding in the pharmacy biological safety cabinet.